Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-17-003138
Filing Date
2017-07-31
Accepted
2017-07-31 17:01:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 PERNIX THERAPEUTICS HOLDINGS, INC. p17-1574sc13g.htm SC 13G 75448
  Complete submission text file 0000902664-17-003138.txt   77278
Mailing Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019 2122874900
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

EIN.: 134131516 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Subject) CIK: 0001024126 (see all company filings)

EIN.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50927 | Film No.: 17993643
SIC: 2834 Pharmaceutical Preparations